Exclusive: The COO of Hims & Hers was the third person to try their GLP-1 drugs—and she’s ready to share her storyBy Press Room14 August 2024 Melissa Baird, a health care executive based in Seattle knows first-hand the stigma around weight at work. “I struggled with…
WeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes aroundBy Press Room14 March 2024 The CEO at WW International, also known as WeightWatchers, told employees in a memo today that the company is on…
Oprah will leave the Weight Watchers board and donate her stake in the company ‘to eliminate any perceived conflict of interest around her taking weight loss medications’By Press Room29 February 2024 Oprah Winfrey is standing down from the board of WW International, also known as WeightWatchers, and the reason why has…
WeightWatchers’ worst month ever—a stark reversal of 2023—wipes out obesity-drug gainsBy Press Room2 February 2024 WW International Inc. suffered its worst month on record in January, erasing the wellness company’s advance since it said in…